{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
AIM ImmunoTech, Inc.
Who are in the management team of AIM ImmunoTech, Inc.?
As of March 2022, the management team of AIM ImmunoTech, Inc. includes Dr. William Mitchell as Chairman of the Board, Mr. Thomas Equels as Executive Vice Chairman, CEO, President, Secretary, and General Counsel, and Mr. Stewart Appelrouth as a Director.
What does AIM ImmunoTech, Inc. do?
AIM ImmunoTech, Inc. is a micro-cap specialty pharmaceutical company focused on developing immune-enhancing therapies for viral and immune-related disorders. As of March 2025, it reported net sales of $0 million and a net loss of $4 million, with a market cap of $7.76 million.
How big is AIM ImmunoTech, Inc.?
As of Jun 18, AIM ImmunoTech, Inc. has a market capitalization of 7.76 million, categorizing it as a Micro Cap company, with net sales of 0.15 million and a net profit of -15.22 million over the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
